Table 2 Patient and transplant characteristics of neuro(+) patients
From: Life-threatening neurological complications after bone marrow transplantation in children
Pt no. | Age (years)/sex | Primary disease | Pretransplant neurological status | Transplant type | Preparative regimen | GvHD prophylaxis | Engraftment |
|---|---|---|---|---|---|---|---|
1 | 16/F | AML(relapse) | Normal | HLA 6/6 sibling BM | BuCy/AraC | CsA/MTX | + |
2 | 7/F | GLD(advanced) | Vegetative state | HLA 5/6 unrelated cord | BuCy/ATG | CsA/MTX | + |
3 | 11/M | AML(CR2) | Normal | HLA 5/6 father PBSC | Bu/Mel/ATG | CsA | + |
4 | 5/M | T.Major(class III) | Normal | HLA 6/6 sibling BM | BuCy | CsA/MTX | + |
5 | 5.5/M | AML(relapse) | Normal | HLA 6/6 sibling BM | BuCy/Mel | CsA | + |
6 | 8/M | AML nonremission(+SCID) | Normal | HLA 6/6 father PBSC | BuCy | CsA/MTX | + |
7 | 16/M | AML(relapse) | Normal | HLA 4/6 father BM | BuCy/Mel/ATG | CsA/MTX/MPZ | + |
8 | 11/M | T.Major(class III) | Normal | HLA 6/6 sibling BM/PBSC | Flu/BuCy | CsA/MTX | + |
9 | 13/M | FAA(aplastic) | Normal | HLA 6/6 sibling BM | BuaCy20 | CsA/MTX | + |
10 | 2/F | Omenn syndrome | Normal | HLA 5/6 mother PBSC | Flu/ATG | CsA | + |
11 | 13/M | FAA(aplastic) | Normal | HLA 6/6 sibling PSBC | Bua/Cy20 | CsA | + |
